Net Income

With the market set to double by 2030, the IAAPI Expo 2026 showcases a sector grappling with rapid growth, new tech, and the critical issue of safety.

As Thames Water faces collapse, a new investigative podcast brings together key experts to dissect the systemic failures behind England's polluted rivers.

The Hong Kong firm is disrupting corporate rewards with a "Cash + Crypto" bonus scheme, aiming to attract top talent and deepen its Web3 integration.

Spatineo launches an AI-powered search tool to help GIS professionals find spatial data in minutes, not days, tackling a costly industry-wide problem.

A new report reveals Gen Z women are rejecting old labels and hustle culture, prioritizing mental health, authentic living, and tech on their own terms.

Genesis Land Development saw record revenues in 2025, but a drop in new orders and a cautious outlook reveal a strategy for a cooling Calgary market.

The Canadian energy firm posted a 12% production jump in 2025, fueled by exploration wins and a major shift to long-life secondary recovery projects.

From Cairo to Hollywood, NYFA alumni and faculty are behind Oscar-nominated films and four international submissions, cementing the school's global impact.

Advantage Energy posts record 2025 results, slashing debt while boosting output and pioneering a major carbon capture project. What's next for the firm?

Ero Copper reports record 2025 production and soaring profits, yet a planned slow start to 2026 has investors weighing near-term hurdles against long-term growth.

After its public debut, BBOT unveils exciting early data from three unique cancer drugs, including a first in pancreatic cancer, backed by a strong cash runway.

The toy giant's new $400M debt offering isn't just about paying bills; it's a strategic move to extend its financial runway and invest in its future.

Digital accessibility leader AudioEye reports record 2025 earnings and unveils a next-gen platform promising enhanced legal protection for businesses.

OFS Credit's net asset value dropped 20% from market volatility, forcing a dividend cut. Can its strategic moves stabilize the ship for investors?

Major deals with Cadillac and Ferrari mark a pivotal year for Research Frontiers, but can its smart glass tech overcome growing financial losses?

aTyr Pharma heads to a crucial FDA meeting for its lung drug efzofitimod, which missed its main goal but showed significant patient quality-of-life gains.

Weebit Nano's advanced memory is at the heart of a South Korean national program aiming to revolutionize AI with ultra-low-power compute-in-memory chips.

As Galapagos pivots its strategy, it brings in a new HR chief to build the high-performing culture crucial for its next chapter of innovation.

As CEO Corie Barry prepares for a key UBS conference, investors seek clarity on Best Buy's strategy for growth amid soft sales and a shifting retail landscape.

NextCure accelerates its high-stakes ovarian cancer drug trial, but with cash dwindling, can it reach the finish line before time runs out?